Fifth Third Bancorp’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.4K | Buy |
511
+228
| +81% | +$3.08K | ﹤0.01% | 3823 |
|
|
2026
Q1 | $3.92K | Buy |
283
+53
| +23% | +$738 | ﹤0.01% | 3920 |
|
|
2025
Q4 | $3.23K | Hold |
230
| – | – | ﹤0.01% | 2380 |
|
|
2025
Q3 | $3.21K | Hold |
230
| – | – | ﹤0.01% | 2401 |
|
|
2025
Q2 | $3.46K | Sell |
230
-21
| -8% | -$300 | ﹤0.01% | 2274 |
|
|
2025
Q1 | $3.31K | Hold |
251
| – | – | ﹤0.01% | 2273 |
|
|
2024
Q4 | $3.96K | Sell |
251
-94
| -27% | -$1.41K | ﹤0.01% | 2209 |
|
|
2024
Q3 | $5.48K | Hold |
345
| – | – | ﹤0.01% | 2162 |
|
|
2024
Q2 | $5.26K | Hold |
345
| – | – | ﹤0.01% | 2113 |
|
|
2024
Q1 | $5.06K | Buy |
345
+130
| +60% | +$1.9K | ﹤0.01% | 2054 |
|
|
2023
Q4 | $2.99K | Hold |
215
| – | – | ﹤0.01% | 2299 |
|
|
2023
Q3 | $2.88K | Hold |
215
| – | – | ﹤0.01% | 2317 |
|
|
2023
Q2 | $2.71K | Sell |
215
-845
| -80% | -$9.86K | ﹤0.01% | 2370 |
|
|
2023
Q1 | $12.1K | Buy |
1,060
+845
| +393% | +$9.12K | ﹤0.01% | 2028 |
|
|
2022
Q4 | $2.23K | Hold |
215
| – | – | ﹤0.01% | 2411 |
|
|
2022
Q3 | $2K | Buy |
215
+125
| +139% | +$1.33K | ﹤0.01% | 2465 |
|
|
2022
Q2 | $1K | Buy |
90
+15
| +20% | +$163 | ﹤0.01% | 2572 |
|
|
2022
Q1 | $1K | Hold |
75
| – | – | ﹤0.01% | 2625 |
|
|
2021
Q4 | $1K | Hold |
75
| – | – | ﹤0.01% | 2633 |
|
|
2021
Q3 | $1K | Hold |
75
| – | – | ﹤0.01% | 2598 |
|
|
2021
Q2 | $1K | Hold |
75
| – | – | ﹤0.01% | 2392 |
|
|
2021
Q1 | $1K | Sell |
75
-40
| -35% | -$514 | ﹤0.01% | 2375 |
|
|
2020
Q4 | $2K | Hold |
115
| – | – | ﹤0.01% | 2242 |
|
|
2020
Q3 | $2K | Hold |
115
| – | – | ﹤0.01% | 2074 |
|
|
2020
Q2 | $1K | Hold |
115
| – | – | ﹤0.01% | 2038 |
|
|
2020
Q1 | $1K | Hold |
115
| – | – | ﹤0.01% | 2063 |
|
|
2019
Q4 | $1K | Hold |
115
| – | – | ﹤0.01% | 2152 |
|
|
2019
Q3 | $1K | Sell |
115
-500
| -81% | -$3.72K | ﹤0.01% | 2121 |
|
|
2019
Q2 | $5K | Buy |
615
+500
| +435% | +$3.93K | ﹤0.01% | 1999 |
|
|
2019
Q1 | $1K | Hold |
115
| – | – | ﹤0.01% | 2109 |
|
|
2018
Q4 | $1K | Hold |
115
| – | – | ﹤0.01% | 2178 |
|
|
2018
Q3 | $1K | Buy |
+115
| New | +$769 | ﹤0.01% | 2153 |
|
|
2017
Q2 | – | Sell |
-310
| Closed | -$2K | – | 2254 |
|
|
2017
Q1 | $2K | Hold |
310
| – | – | ﹤0.01% | 1995 |
|
|
2016
Q4 | $3K | Sell |
310
-630
| -67% | -$5.86K | ﹤0.01% | 2017 |
|
|
2016
Q3 | $9K | Buy |
+940
| New | +$8.97K | ﹤0.01% | 1859 |
|
|
2016
Q1 | – | Sell |
-56,705
| Closed | -$525K | – | 2611 |
|
|
2015
Q4 | $525K | Sell |
56,705
-29,420
| -34% | -$322K | ﹤0.01% | 716 |
|
|
2015
Q3 | $1.1M | Buy |
86,125
+13,335
| +18% | +$166K | 0.01% | 528 |
|
|
2015
Q2 | $805K | Buy |
72,790
+5,995
| +9% | +$66.2K | 0.01% | 616 |
|
|
2015
Q1 | $763K | Buy |
66,795
+5,370
| +9% | +$57K | 0.01% | 640 |
|
|
2014
Q4 | $620K | Buy |
61,425
+375
| +0.6% | +$3.95K | 0.01% | 673 |
|
|
2014
Q3 | $642K | Buy |
61,050
+170
| +0.3% | +$1.6K | 0.01% | 668 |
|
|
2014
Q2 | $525K | Buy |
60,880
+57,545
| +1,725% | +$484K | ﹤0.01% | 695 |
|
|
2014
Q1 | $29K | Buy |
3,335
+2,570
| +336% | +$22.4K | ﹤0.01% | 1645 |
|
|
2013
Q4 | $6K | Buy |
765
+50
| +7% | +$396 | ﹤0.01% | 1957 |
|
|
2013
Q3 | $5K | Hold |
715
| – | – | ﹤0.01% | 2023 |
|
|
2013
Q2 | $5K | Buy |
+715
| New | +$5.22K | ﹤0.01% | 1929 |
|
Other funds holding RDY
AIM
Fifth Third Bancorp's RDY Position: Q2 2026 in Review
Fifth Third Bancorp increased its Dr. Reddy's Laboratories (RDY) stake by 81% in Q2 2026, buying an estimated $3.08K and bringing the position to 511 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3823.
Fifth Third Bancorp first reported a position in RDY in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.1M in Q3 2015. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Fifth Third Bancorp held 511 shares of Dr. Reddy's Laboratories worth $7.4K as of Q2 2026.
- Fifth Third Bancorp bought 228 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.08K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3823 holding.
- Fifth Third Bancorp first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 46 quarters since.
- Fifth Third Bancorp's Dr. Reddy's Laboratories position peaked at $1.1M in Q3 2015.
- 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.